lilly tirzepatide lawsuit Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a Tuesday against the pharmaceutical company Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound novo nordisk tirzepatide Nordisk's CagriSema

Check for any cloudiness, particles, or color changes that were not present before the exposure

Implications of the era of incretin-based weight loss therapy in menopause

Semaglutide aids in weight loss but diet and exercise are still important

The effect of acute caffeine intake on insulin sensitivity and glycemic control in people with diabetes

The November 2025 federal budget allocated no new pharmacare funding

This specific localization within the GCL is of profound clinical relevance, as retinal ganglion cells are the primary neurons that degenerate in glaucoma and are also critically affected during the early neurodegenerative stages of diabetic retinopathy [38, 39]